Clinical Trial Update: RecoverPC: Relugolix vs GnRH Agonist in Quality of Life [Phase 2]

View source ↗

Summary

A Phase 2 trial called RecoverPC is evaluating relugolix versus a GnRH agonist to assess quality of life in prostate cancer, and the study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)
• Relugolix (Relugolix)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer, Prostatic Neoplasms | Phase 2 | Status: RECRUITING